Blood Viscosity:
A Major Player in Heart Disease
(And what you can do about it)
By
Dr. Anthony G. Payne
One of the lynchpins of the plague-building process in
people is blood viscosity. When blood is viscous -- think of Karo syrup or
"grade D motor sludge" -- it damages blood vessel walls. The cells
that line damaged arteries and veins will attempt to adapt to the assault and
offset the impact by actually building up plague ("Atheromas" in
medical parlance). This, at least, is the contention of researcher Kenneth
Kensey, MD of Rheologics, Inc. (www.rheologics.com).
Dr. Kensey's contentions are well argued, supported by lots of data, and are
logical and forthright.
If you smoke, have high blood pressure, are diabetic, drink excessively, do
drugs, have a high homocysteine level, etc. -- guess what? Blood viscosity goes
up! As does the risk of developing significant blockage in circulatory vessels
that are get the blunt of the movement ("shear stress) of this sticky,
viscous blood.
Since heart disease is the #1 killer of adult Americans, it follows that a lot
of us are walking around with "grade D motor sludge" in our
circulatory systems. How can this viscosity be reduced so that the damage will
slow or stop -- if not reverse?
Here are some of the things high risk people can do:
· If you smoke, you should stop
· If you drink excessively, you should curtail
your intake or stop
· If you use recreational drugs, stop doing so
and look into IV therapy to help your body repair the multiorgan damage
( Call 1-800-300-1064 and ask Laura, Noyemy or Kathy
about the IV detox program. )
· Take a B multiple. This will help the body
deal with artery-damaging homocysteine
· Take an antioxidant supplement (Antioxidants
help the body deal with the cell damaging free radicals generated by viscous
blood)
· If you are obese, get the excess weight off
slowly under medical supervision ("The Paleodiet" is highly
recommended)
· Eat food low in saturated fat. Favor omega-3
rich foods over those high in omega 6 fatty acids
(Check out the paleo diet http://14ushop.com/wizard/living-longer.html)
· If you are diabetic, keep your condition
under control and ask your doctor about Carnosine and other protective factors
· If your LDL ("bad cholesterol") is
high, work with your MD or DO and/or an RD to reduce this
· If your triglycerides or fibrinogen are high,
ask your MD or DO about niacin or other approaches to reducing this
· Clean up dental infections and inflammation
in the body (Make sure your MD or DO monitors your C-reactive protein level)
·
If you are stressed out or depressed, consider stress management courses
and/or Cognitive Therapy
Consume lots of brown algae foods such as Wakame, Kombu, and such. These alga
contain compounds called heparin-like fucoidans that act as mild blood
thinners (Which reduces blood viscosity).
© 2004 by
Dr. Anthony G. Payne. All rights reserved, but feel free to spread the word!
_______________________________________________________________
Thromb Res. 2001 Dec 1;104(5):371-4. , Links
Changes in blood viscosity by heparin and argatroban.
Hitosugi M, Niwa M, Takatsu A.
Department of Forensic Medicine, Jikei University School of Medicine, 3-25-8
Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan. hitosugi@jikei.ac.jp
Anticoagulants are effective for preventing both venous and arterial
thrombosis. Although antithrombotic agents have been reported to reduce
thrombin formation, to our knowledge, the relation between blood viscosity (BV)
and antithrombotic agents has not been examined. We examined the effects on
whole BV of various dosages of the antithrombotic agents-heparin sodium and
argatroban. Thirty microliters of either drug was added to 3-ml samples of
blood obtained from healthy male volunteers. Whole BV was then immediately
examined with an oscillation-type viscometer. When either agent was added, BV
decreased and coagulation time increased dose dependently. BV was 4.5+/-0.3
mPa.s in untreated blood but decreased in a dose-dependent manner to a minimum
of 2.5+/-0.3 mPa.s with heparin sodium and decreased dose dependently in a
sigmoid manner with argatroban. Because thrombin generation is inhibited in all
antithrombotic therapies, this inhibition might be reflected by changes in BV.
Our results suggest that BV in accordance with blood coagulability are indexes
of thrombotic tendency and that decreasing BV prevents life-threatening
thromboembolic conditions.